- Home
- VRDN vs ARDT Comparison
VRDN vs ARDT Comparison
Compare VRDN & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- ARDT
- Stock Information
- Founded
- VRDN 2006
- ARDT 2001
- Country
- VRDN United States
- ARDT United States
- Employees
- VRDN N/A
- ARDT N/A
- Industry
- VRDN Medical Specialities
- ARDT
- Sector
- VRDN Health Care
- ARDT
- Exchange
- VRDN Nasdaq
- ARDT NYSE
- Market Cap
- VRDN 1.6B
- ARDT 1.7B
- IPO Year
- VRDN N/A
- ARDT 2024
- Fundamental
- Price
- VRDN $12.39
- ARDT $14.54
- Analyst Decision
- VRDN Buy
- ARDT Buy
- Analyst Count
- VRDN 14
- ARDT 13
- Target Price
- VRDN $36.82
- ARDT $20.85
- AVG Volume (30 Days)
- VRDN 887.1K
- ARDT 306.0K
- Earning Date
- VRDN 05-06-2025
- ARDT 05-06-2025
- Dividend Yield
- VRDN N/A
- ARDT N/A
- EPS Growth
- VRDN N/A
- ARDT 935.52
- EPS
- VRDN N/A
- ARDT 1.64
- Revenue
- VRDN $302,000.00
- ARDT $6,024,260,000.00
- Revenue This Year
- VRDN N/A
- ARDT $8.18
- Revenue Next Year
- VRDN $20,553.29
- ARDT $5.58
- P/E Ratio
- VRDN N/A
- ARDT $8.85
- Revenue Growth
- VRDN 4.86
- ARDT 8.91
- 52 Week Low
- VRDN $9.90
- ARDT $11.31
- 52 Week High
- VRDN $27.20
- ARDT $20.72
- Technical
- Relative Strength Index (RSI)
- VRDN 42.19
- ARDT N/A
- Support Level
- VRDN $11.76
- ARDT N/A
- Resistance Level
- VRDN $13.63
- ARDT N/A
- Average True Range (ATR)
- VRDN 0.75
- ARDT 0.00
- MACD
- VRDN -0.02
- ARDT 0.00
- Stochastic Oscillator
- VRDN 22.11
- ARDT 0.00
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About ARDT ARDENT HEALTH PARTNERS INC
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services predominantly through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operate across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.